Mc Cullough, Lauren E, et al. Cross-sectional Associations Between Body Size, Circulating Sex-steroid Hormones and Igf Components Among Healthy Chinese Women. 2015. https://doi.org/10.17615/pdy5-7n71
Mc Cullough, L., Miller, E., Wang, Q., Li, J., Liu, L., Li, H., Zhang, J., & Smith, J. (2015). Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women. https://doi.org/10.17615/pdy5-7n71
Mc Cullough, Lauren E., Erline E Miller, Qiong Wang, Jia Yuan Li, Li Liu, Hui Li, Jing Zhang et al. 2015. Cross-Sectional Associations Between Body Size, Circulating Sex-Steroid Hormones and Igf Components Among Healthy Chinese Women. https://doi.org/10.17615/pdy5-7n71
The incidence of breast cancer has increased in Asian countries and rates of hormone receptor (HR) negative breast cancer exceed those of Western countries. Epidemiologic data suggest that the association between body size and BC risk may vary by HR status, and could differ geographically. While body size may influence BC risk by moderating the synthesis and metabolism of circulating sex-steroid hormones, insulin-like growth factor (IGF)-1 and related binding proteins, there is a dearth of literature among Asian women. We aimed to examine these specific associations in a sample of Chinese women. In Sichuan Province 143 women aged ≥40 years were recruited through outpatient services (2011–2012). Questionnaires, anthropometric measurements, and blood samples were utilized for data collection and linear regression was applied in data analyses. Among women <50 years we observed a non-monotonic positive association between body mass index (BMI) and 17β-estradiol, and a reversed J-shaped association between BMI and IGF-1 (p ≤0.05). We observed similar associations between waist-to-hip ratio and these markers. Our finding of augmented IGF-1 among women with low body mass may have implications for understanding breast tumor heterogeneity in diverse populations and should be evaluated in larger prospective studies with cancer outcomes.